Dashboard
Manage Tickers

BSVNBank7 Corp.

Nasdaq bank7.com


$ 29.90 $ -0.25 (-0.84 %)    

Wednesday, 12-Jun-2024 15:58:54 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 476.76 $ 6.13 (1.31 %)
DIA $ 387.57 $ -0.28 (-0.07 %)
SPY $ 541.15 $ 4.41 (0.82 %)
TLT $ 92.53 $ 0.69 (0.75 %)
GLD $ 214.71 $ 0.57 (0.27 %)
$ 29.54
$ 30.05
$ 0.00 x 0
$ 30.14 x 100
$ 29.50 - $ 30.05
$ 19.23 - $ 30.83
6,155
na
275.25M
$ 1.03
$ 9.19
TBD
na
na ($ 0.03)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-15-2024 03-31-2024 10-Q
2 03-25-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-09-2023 06-30-2023 10-Q
5 05-15-2023 03-31-2023 10-Q
6 03-24-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-15-2022 06-30-2022 10-Q
9 05-13-2022 03-31-2022 10-Q
10 03-31-2022 12-31-2021 10-K
11 11-05-2021 09-30-2021 10-Q
12 08-13-2021 06-30-2021 10-Q
13 05-11-2021 03-31-2021 10-Q
14 03-25-2021 12-31-2020 10-K
15 11-16-2020 09-30-2020 10-Q
16 08-14-2020 06-30-2020 10-Q
17 05-14-2020 03-31-2020 10-Q
18 03-30-2020 12-31-2019 10-K
19 11-14-2019 09-30-2019 10-Q
20 08-13-2019 06-30-2019 10-Q
21 05-15-2019 03-31-2019 10-Q
22 03-29-2019 12-31-2018 10-K
23 11-14-2018 09-30-2018 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

around-1m-bet-on-biohaven-check-out-these-4-stocks-insiders-are-buying
Around $1M Bet On Biohaven? Check Out Thes...
04/26/2024 11:36:41

bank7-q1-eps-121-beats-105-estimate-sales-2402m-miss-2505m-estimate
Bank7 Q1 EPS $1.21 Beats $1.05 Estimate, S...
04/12/2024 12:03:28

Bank7 (NASDAQ:BSVN) reported quarterly earnings of $1.21 per share which beat the analyst consensus estimate of $1.05 by 15.24 ...

earnings-scheduled-for-april-12-2024
Earnings Scheduled For April 12, 2024
04/12/2024 11:17:58

Companies Reporting Before The Bell • Progressive (NYSE:PGR) is projected to report quarterly earnings at $3.17 per share on r...

stephens--co-reiterates-equal-weight-on-bank7-maintains-31-price-target
Stephens & Co. Reiterates Equal-Weight on ...
01/30/2024 17:35:49

Stephens & Co. analyst Matt Olney reiterates Bank7 (NASDAQ:BSVN) with a Equal-Weight and maintains $31 price target.

keefe-bruyette--woods-maintains-outperform-on-bank7-raises-price-target-to-40-report-released-on-29-january-2024
Keefe, Bruyette & Woods Maintains Outperfo...
01/30/2024 13:37:59

Keefe, Bruyette & Woods analyst Brady Gailey maintains Bank7 (NASDAQ:BSVN) with a Outperform and raises the price target...

recap-bank7-q4-earnings
Recap: Bank7 Q4 Earnings
01/29/2024 13:10:06

bank7-q4-eps-012-beats-009-estimate-sales-2807m-beat-2160m-estimate
Bank7 Q4 EPS $0.12 Beats $0.09 Estimate, S...
01/29/2024 13:07:03

Bank7 (NASDAQ:BSVN) reported quarterly earnings of $0.12 per share which beat the analyst consensus estimate of $0.09 by 33.33 ...

bank7-earnings-preview
Bank7 Earnings Preview
01/26/2024 16:01:17

bank7-announces-renewal-of-stock-repurchase-plan-of-up-to-750000-shares
Bank7 Announces Renewal Of Stock Repurchas...
10/30/2023 20:47:51

Bank7 Corp. (NASDAQ:BSVN) ("the Company"), the parent company of Oklahoma City-based Bank7, announced today that its bo...

piper-sandler-maintains-overweight-on-bank7-lowers-price-target-to-27
Piper Sandler Maintains Overweight on Bank...
10/30/2023 16:07:27

Piper Sandler analyst Nathan Race maintains Bank7 (NASDAQ:BSVN) with a Overweight and lowers the price target from $32 to $27.

stephens--co-maintains-equal-weight-on-bank7-lowers-price-target-to-24
Stephens & Co. Maintains Equal-Weight on B...
10/27/2023 15:29:20

Stephens & Co. analyst Matt Olney maintains Bank7 (NASDAQ:BSVN) with a Equal-Weight and lowers the price target from $27...

bank7-q3-eps-085-misses-100-estimate-sales-2175m-beat-2093m-estimate
Bank7 Q3 EPS $0.85 Misses $1.00 Estimate, ...
10/26/2023 12:03:28

Bank7 (NASDAQ:BSVN) reported quarterly earnings of $0.85 per share which missed the analyst consensus estimate of $1.00 by 15 p...

friday-is-your-last-chance-to-buy-bank7-before-the-dividend-payout
Friday Is Your Last Chance To Buy Bank7 Be...
09/20/2023 14:45:21

bank7-corp-announces-quarterly-dividend-increase-from-016-to-021share
Bank7 Corp. Announces Quarterly Dividend I...
07/31/2023 13:16:54

 Bank7 Corp. (NASDAQ:BSVN), the parent company of Oklahoma City-based Bank7 (the "Company"), is pleased to announce tha...

correction-bank7-q2-eps-105-beats-096-estimate-sales-2129m-beat-2069m-estimate
CORRECTION: Bank7 Q2 EPS $1.05 Beats $0.96...
07/20/2023 13:10:32

Bank7 (NASDAQ:BSVN) reported quarterly earnings of $1.05 per share which beat the analyst consensus estimate of $0.96 by 9.38 p...

bank7-q2-eps-105-beats-096-estimate-sales-2129m-beat-2069m-estimate
Bank7 Q2 EPS $1.05 Beats $0.96 Estimate, S...
07/20/2023 13:07:46

Bank7 (NASDAQ: BSVN) reported quarterly earnings of $1.05 per share which beat the analyst consensus estimate of $0.96 by 9.38 ...

bank7-q2-eps-105-beats-096-estimate
Bank7 Q2 EPS $1.05 Beats $0.96 Estimate
07/20/2023 13:03:49

Bank7 (NASDAQ:BSVN) reported quarterly earnings of $1.05 per share which beat the analyst consensus estimate of $0.96 by 9.38 p...

bank7-earnings-preview
Bank7 Earnings Preview
07/19/2023 19:01:04

bank7-dividend-insights
Bank7: Dividend Insights
06/16/2023 14:45:41

piper-sandler-maintains-overweight-on-bank7-lowers-price-target-to-31
Piper Sandler Maintains Overweight on Bank...
05/01/2023 13:35:32

Piper Sandler analyst Nathan Race maintains Bank7 (NASDAQ:BSVN) with a Overweight and lowers the price target from $36 to $31.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)